Characteristics of Randomized Patients
Characteristic | CRP Assistance | Control |
---|---|---|
COPD=chronic obstructive pulmonary disease; FP=family physician; IQR=interquartile range; VAS=visual analog scale. | ||
a There were 106 responses from both groups for education level. | ||
b Scored on a range from 0–100 (with 100 being most severe). | ||
Demographics | n=129 | n=129 |
Female, % (n) | 68.2 (88) | 70.5 (91) |
Age, mean (SD), y | 43.0 (13.4) | 45.5 (14.0) |
Lower education, % (n)a | 29.2 (31) | 19.8 (21) |
Secondary education, % (n)a | 43.4 (46) | 42.5 (45) |
Higher education, % (n)a | 27.4 (29) | 37.7 (40) |
Current smoking, % (n) | 30.8 (33) | 25.5 (27) |
Comorbidity | n=129 | n=129 |
COPD, % (n) | 3.9 (5) | 2.3 (3) |
Asthma, % (n) | 7.8 (10) | 7.0 (9) |
Allergic rhinitis, % (n) | 10.1 (13) | 9.3 (12) |
Diabetes mellitus, % (n) | 7.0 (9) | 3.1 (4) |
Heart disease, % (n) | 4.7 (6) | 6.2 (8) |
Lower respiratory tract infection, n | n=56 | n=51 |
Shortness of breath, % (n) | 66.1 (37) | 58.8 (30) |
Wheezing, % (n) | 39.3 (22) | 29.4 (15) |
Chest pain, % (n) | 51.8 (29) | 56.9 (29) |
Auscultation abnormalities, % (n) | 44.6 (25) | 41.2 (21) |
Fever, % (n) | 48.2 (27) | 49.0 (25) |
Perspiring, % (n) | 51.8 (29) | 41.2 (21) |
Headache, % (n) | 32.1 (18) | 43.1 (22) |
Myalgia, % (n) | 46.4 (26) | 49.0 (25) |
Generally feeling unwell, % (n) | 75.0 (42) | 78.4 (40) |
Duration of symptoms, mean (SD), d | 8.07 (5.12) | 8.82 (6.16) |
Duration of symptoms, median (IQR), d | 7 (5–14) | 7 (4–14) |
VAS illness severity score by physician, mean (mm, SD)b | 46.16 (22.92) | 42.07 (23.07) |
Rhinosinusitis | n=73 | n=78 |
History of rhinorrhea, % (n) | 71.2 (52) | 76.9 (60) |
Purulent rhinorrhea, % (n) | 52.1 (38) | 56.4 (44) |
Blocked nose, % (n) | 78.1 (57) | 75.6 (59) |
Unilateral facial pain, % (n) | 53.4 (39) | 56.4 (44) |
Headache, % (n) | 69.9 (51) | 76.9 (60) |
Dental pain, % (n) | 34.2 (25) | 28.2 (22) |
Pain at chewing, % (n) | 19.2 (14) | 10.3 (8) |
Pain at bending over, % (n) | 60.3 (44) | 66.7 (52) |
Worsening symptoms after initial improvement, % (n) | 19.2 (14) | 25.6 (20) |
Duration of symptoms, mean (SD), d | 9.28 (6.70) | 10.04 (6.85) |
Duration of symptoms, median (IQR), d | 7 (4–14) | 8 (5–14) |
VAS illness severity score by physician, mean (mm, SD)b | 40.61 (22.28) | 40.51 (21.05) |